What Does Rome Therapeutics Do?

Total employees75
HeadquartersCambridge
Founded2020

Rome Therapeutics is a biotechnology company focused on pioneering a new class of medicines by targeting the vast, under-explored region of the human genome known as the repeatome. The company aims to translate insights from this "dark genome" into transformative therapies for serious diseases, initially focusing on cancer and autoimmune disorders. By understanding how repetitive sequences of DNA impact cellular function and disease, Rome is developing novel drugs against previously undruggable targets.

Where Is Rome Therapeutics's Headquarters?

HQ Function

The Cambridge headquarters serves as the central hub for Rome's research and development operations, strategic planning, and corporate administration. It houses state-of-the-art laboratories and office spaces.

Notable Features:

Located in Technology Square, a renowned center for innovation and life sciences, providing access to a rich ecosystem of academic institutions, research organizations, and other biotech companies. Facilities likely include advanced molecular biology, biochemistry, and cell biology labs.

Work Culture:

A dynamic, science-driven, and collaborative environment, typical of innovative biotech startups, with an emphasis on cutting-edge research, teamwork, and a mission-oriented approach to drug discovery.

HQ Significance:

The Cambridge location places Rome Therapeutics at the epicenter of biotechnological innovation, facilitating collaborations, talent acquisition, and access to leading research and venture capital.

Values Reflected in HQ: The choice of a premier biotech hub reflects Rome's commitment to scientific excellence, innovation, and being at the forefront of therapeutic development.

Location:

While headquartered in the US, Rome Therapeutics operates within the global biopharmaceutical ecosystem. Its research into the repeatome has global implications for treating diseases like cancer and autoimmune disorders. The company may engage in international collaborations with academic institutions, research partners, and clinical trials across different regions. Its investor base also includes international entities, reflecting a global interest in its innovative science.

Street Address:

400 Technology Square, 9th Floor

City:

Cambridge

State/Province:

MA

Country:

USA

Where Else Does Rome Therapeutics Operate Around the World?

N/A - Operations Centralized

Address: N/A

Focus on centralized operations at the main R&D and corporate hub to foster close collaboration and streamline development efforts.

Buying Intent Signals for Rome Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Rome Therapeutics? Meet the Executive Team

As of April 2025, Rome Therapeutics' leadership includes:

Rosana Kapeller, M.D., Ph.D. - President, Chief Executive Officer and Co-founder
Jeff Hatfield - Executive Chair
Dennis Zaller, Ph.D. - Chief Scientific Officer
Elena Verbeke, J.D., Ph.D. - Chief Business Officer & General Counsel
Menachem Fromer, Ph.D. - Chief Data Science Officer
Karen Zaderej - Chief People Officer
David Proia, Ph.D. - SVP, Head of Oncology
Sarah Knutson, Ph.D. - SVP, Head of Repeat Biology

Who's Investing in Rome Therapeutics?

Rome Therapeutics has been backed by several prominent investors over the years, including:

GV (Google Ventures)
ARCH Venture Partners
Andreessen Horowitz (a16z)
GGV Capital
Section 32
Sanofi Ventures
Casdin Capital
Euclidean Capital
Mirae Asset Venture Investment

What Leadership Changes Has Rome Therapeutics Seen Recently?

Hire1
Exits0

In the past 12 months (May 2023 - May 2024), Rome Therapeutics has strengthened its leadership team with a key C-suite appointment in human resources. No major executive departures have been publicly announced during this period.

New Appointments:

Karen Zaderej, Karen Zaderej appointed as Chief People Officer, bringing extensive experience in human resources and talent management within the biopharmaceutical industry.

What Technology (Tech Stack) Is Used byRome Therapeutics?

Discover the tools Rome Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Rome Therapeutics Email Formats and Examples

Rome Therapeutics appears to utilize a common corporate email format. Based on publicly available information, such as contact details in press releases or conference materials, and standard industry practices, the most likely format is the first initial of the first name followed by the full last name.

[first_initial][last]@rometherapeutics.com

Format

rkapeller@rometherapeutics.com

Example

85%

Success rate

What's the Latest News About Rome Therapeutics?

Business Wire • May 9, 2023

ROME Therapeutics Appoints Karen Zaderej as Chief People Officer

ROME Therapeutics announced the appointment of Karen Zaderej as Chief People Officer. Ms. Zaderej brings extensive experience in human resources and talent management within the biopharmaceutical industry and will lead ROME's efforts to attract, develop, and retain top talent....more

PR Newswire • February 14, 2023

Rome Therapeutics Completes $72 Million Series B Extension Financing to Advance Pipeline of Novel Repeat-Targeting Therapies

Rome Therapeutics announced the completion of a $72 million extension to its Series B financing, bringing the total Series B round to $149 million. The funding will support the advancement of its lead program, an LTR-retrotransposon inhibitor for autoimmune disease, into clinical development and further progress its oncology pipeline....more

Business Wire • January 5, 2023

ROME Therapeutics Appoints Menachem Fromer, Ph.D. as Chief Data Science Officer

ROME Therapeutics announced the appointment of Menachem Fromer, Ph.D., as Chief Data Science Officer. Dr. Fromer will lead the company's data science strategy and computational platform to further unlock the therapeutic potential of the repeatome....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Rome Therapeutics, are just a search away.